These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36444513)

  • 1. Health status and cognitive function for risk stratification in chronic coronary and peripheral artery disease.
    Smolderen KG; Mena-Hurtado C; Eikelboom JW; Bosch J; Xie F; Ramasundarahettige C; Bhatt DL; Anand SS
    Eur J Prev Cardiol; 2023 May; 30(7):535-545. PubMed ID: 36444513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort.
    Wan D; Dehghan M; de Souza RJ; Ramasundarahettige C; Eikelboom JW; Bosch J; Maggioni AP; Bhatt DL; Yusuf S; Anand SS
    Eur J Prev Cardiol; 2023 Jun; 30(8):709-718. PubMed ID: 37080912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
    Grenon SM; Vittinghoff E; Owens CD; Conte MS; Whooley M; Cohen BE
    Vasc Med; 2013 Aug; 18(4):176-84. PubMed ID: 23835937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.
    Qamar A; Morrow DA; Creager MA; Scirica BM; Olin JW; Beckman JA; Murphy SA; Bonaca MP
    Vasc Med; 2020 Apr; 25(2):124-132. PubMed ID: 32000630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease.
    Berger A; Simpson A; Bhagnani T; Leeper NJ; Murphy B; Nordstrom B; Ting W; Zhao Q; Berger JS
    Am J Cardiol; 2019 Jun; 123(12):1893-1899. PubMed ID: 31014542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral artery disease, lower limb revascularization, and amputation in diabetes patients with and without coronary artery disease: a cohort study from the Western Denmark Heart Registry.
    Olesen KKW; Gyldenkerne C; Thim T; Thomsen RW; Maeng M
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33414173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
    Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
    JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease.
    Sprenger L; Mader A; Larcher B; Mächler M; Vonbank A; Zanolin-Purin D; Leiherer A; Muendlein A; Drexel H; Saely CH
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34782334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial.
    Rymer JA; Mulder H; Smolderen KG; Hiatt WR; Conte MS; Berger JS; Norgren L; Mahaffey KW; Baumgartner I; Fowkes FG; Katona BG; Rockhold F; Jones WS; Patel MR
    J Am Heart Assoc; 2020 Oct; 9(19):e016573. PubMed ID: 32924754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic events in atrial fibrillation: Different level of risk and pattern between peripheral artery disease and coronary artery disease.
    Lin YS; Wu VC; Chen YL; Liu CH; Chen HC; Lee WC; Yang TY; Aboyans V; Chen MC
    Arch Cardiovasc Dis; 2021 Mar; 114(3):176-186. PubMed ID: 33518472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of preexisting coronary artery and peripheral artery disease on outcomes in diabetic patients after kidney transplant.
    Jiwani S; Chan WC; Majmundar M; Patel KN; Mehta H; Sharma A; Parmar G; Wiley M; Tadros P; Hockstad E; Yarlagadda SG; Gupta A; Gupta K
    Vasc Med; 2024 Apr; 29(2):135-142. PubMed ID: 37936422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of peripheral artery disease and polyvascular disease in patients with end-stage kidney disease.
    Mehta H; Chan WC; Aday AW; Jones WS; Parmar GM; Hance K; Thors A; Alli A; Wiley M; Tadros P; Gupta K
    J Vasc Surg; 2024 May; 79(5):1170-1178.e10. PubMed ID: 38244643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum resistin is associated with impaired endothelial function and a higher rate of adverse cardiac events in patients with peripheral artery disease.
    Ramirez JL; Khetani SA; Zahner GJ; Spaulding KA; Schaller MS; Gasper WJ; Hills NK; Schafer AL; Grenon SM
    J Vasc Surg; 2019 Feb; 69(2):497-506. PubMed ID: 30292618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease.
    Branch KR; Probstfield JL; Eikelboom JW; Bosch J; Maggioni AP; Cheng RK; Bhatt DL; Avezum A; Fox KAA; Connolly SJ; Shestakovska O; Yusuf S
    Circulation; 2019 Aug; 140(7):529-537. PubMed ID: 31163978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Incidence of Adverse Clinical Outcomes Among People With Coronary Artery Disease and/or Peripheral Artery Disease in Relation to Vascular Risk in the United States.
    Desai U; Babcock A; Wang Y; Akbarnejad H; Lemus Wirtz E; Laliberte F; Lefebvre P; Kharat A
    Am J Cardiol; 2023 Dec; 208():44-52. PubMed ID: 37812866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006-2015.
    Sundaram V; Bloom C; Zakeri R; Halcox J; Cohen A; Bowrin K; Briere JB; Banerjee A; Simon DI; Cleland JGF; Rajagopalan S; Quint JK
    Eur Heart J; 2020 May; 41(17):1636-1649. PubMed ID: 31883328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
    Emery C; Torreton E; Briere JB; Evers T; Fagnani F
    J Med Econ; 2020 May; 23(5):513-520. PubMed ID: 31928390
    [No Abstract]   [Full Text] [Related]  

  • 19. Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease.
    Berger A; Simpson A; Leeper NJ; Murphy B; Nordstrom B; Ting W; Zhao Q; Berger J
    Adv Ther; 2020 Jan; 37(1):240-252. PubMed ID: 31705434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of socioeconomic insecurity in peripheral and coronary artery disease patients.
    Joly M; Gillois P; Satger B; Blaise S; Pernod G
    J Med Vasc; 2022; 47(5-6):220-227. PubMed ID: 36464416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.